Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study

Author:

Raimondo Annunziata1ORCID,Amerio Paolo2,Balato Anna3,Cusano Francesco4,Fargnoli Maria Concetta5ORCID,Guarneri Claudio6,Ligrone Luigi7,Megna Matteo8ORCID,Musumeci Maria Letizia9,Puca Rosa Valentina10,Uzzauto Maria Teresa11,Lembo Serena1

Affiliation:

1. Department of Medicine Surgery and Dentistry, “Scuola Medica Salernitana” University of Salerno Salerno Italy

2. Dermatology Unit University of G. D'Annunzio Chieti Italy

3. Dermatology Unit University of Campania Luigi Vanvitelli Naples Italy

4. Dermatology Unit, “G. Rummo” Hospital Benevento Italy

5. Dermatology, Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy

6. Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Section of Dermatology University of Messina Messina Italy

7. Dermatology Unit San Giovanni di Dio e Ruggi D'Aragona University Hospital Salerno Italy

8. Section of Dermatology, Department of Clinical, Medicine and Surgery University of Naples Federico II Naples Italy

9. Department of Dermatology University of Catania Catania Italy

10. Dermatology and Dermosurgery, “San Giuseppe Moscati” National Hospital (AORN) Contrada Amoretta Avellino Italy

11. Dermatology Unit, A. Tortora Hospital Pagani Salerno Italy

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3